UVA Absorption Mechanism of Avobenzone: Keto–Enol Tautomerism, Photochemical Instability, and Formulation Photostabilization Strategies
UVA Absorption Mechanism of Avobenzone: Keto–Enol Tautomerism, Photochemical Instability, and Formulation Photostabilization Strategies
1 Basic Properties and Protective Wavelength Range of Avobenzone
1.1 Basic Chemical Information
The International Nomenclature Cosmetic Ingredient name of avobenzone is Butyl Methoxydibenzoylmethane. Its Chinese chemical name is butyl methoxydibenzoylmethane. It is a dibenzoylmethane derivative and a β-diketone compound.[1]
Item | Details |
Common name | Avobenzone |
INCI name | Butyl Methoxydibenzoylmethane |
CAS No. | 70356-09-1 |
Molecular formula | C₂₀H₂₂O₃ |
Relative molecular mass | 310.39 |
Appearance | White to pale-yellow crystalline powder |
Solubility | Practically insoluble in water; soluble in various cosmetic oils and organic solvents |
Main protective wavelength range | Ultraviolet A |
Maximum absorption wavelength | Usually approximately 357 nm, depending on the solvent and formulation environment |

The diketo skeleton of avobenzone can be represented in simplified form as:
Ar¹—CO—CH₂—CO—Ar²
where:
① Ar¹ represents an aromatic ring bearing a tert-butyl substituent;
② Ar² represents an aromatic ring bearing a methoxy substituent.
The two aromatic rings and the central β-dicarbonyl structure together determine its electron distribution, oil solubility, tautomerism, and ultraviolet absorption characteristics.
1.2 Which Region of Ultraviolet Radiation Does Avobenzone Primarily Absorb?
Ultraviolet radiation reaching the Earth’s surface and closely associated with sunscreen evaluation is commonly divided into:
① Ultraviolet B (UVB): approximately 290–320 nm;
② Ultraviolet A2 (UVA2): approximately 320–340 nm;
③ Ultraviolet A1 (UVA1): approximately 340–400 nm.
The absorption band of avobenzone covers UVA2 and extends into UVA1, with its maximum absorption generally located at approximately 357 nm. Its principal role in sunscreen formulations is therefore to supplement long-wave UVA absorption above 340 nm.[2]
The absorption of avobenzone gradually decreases as the wavelength approaches 400 nm. It also cannot provide complete UVB protection when used alone and therefore usually needs to be combined with UVB filters and other UVA filters.
2 Molecular Basis of UVA Absorption by Avobenzone

2.1 Keto–Enol Tautomerism
Avobenzone contains a β-diketone structure and exists in tautomeric equilibrium between the diketo and enol forms:
Diketo form:
Ar¹—CO—CH₂—CO—Ar²
Enol form:
Ar¹—CO—CH=C(OH)—Ar²
Tautomerization involves not only a change in the position of the hydrogen atom but also a rearrangement of the carbonyl group and carbon–carbon double bond.
In many organic solvents and sunscreen oil phases, ground-state avobenzone exists predominantly in the chelated enol form. The enolic hydroxyl group can form an intramolecular hydrogen bond with the adjacent carbonyl oxygen:
Ar¹—CO···H—O—C=CH—Ar²
This intramolecular hydrogen bond forms a chelated structure resembling a six-membered ring, which helps maintain the planarity of the central molecular framework and stabilizes the enol form.[2][3]
2.2 Why Can the Chelated Enol Form Absorb Long-Wave UVA?
The relationship between photon energy and wavelength is expressed as follows:
E = hc/λ
where:
• E is the photon energy;
• h is Planck’s constant;
• c is the speed of light;
• λ is the wavelength of light.
The longer the wavelength, the lower the energy of an individual photon. For a molecule to absorb long-wave UVA, the energy gap between its electronic ground state and excited state must correspond to the energy of these lower-energy photons.
In the chelated enol form, the aromatic rings, carbon–carbon double bond, and carbonyl group form a relatively continuous π-electron conjugated system. The π electrons can be delocalized over a relatively large region, reducing the energy difference between the relevant molecular orbitals and thereby enabling the absorption of longer-wavelength UVA photons.
The electron-donating effect of the methoxy group, the substitution patterns of the two aromatic rings, and the degree of molecular planarity also influence electron delocalization and the position of the absorption maximum. Changes in solvent polarity, hydrogen bonding, and the local microenvironment can therefore alter both the absorption maximum and absorption intensity of avobenzone.[2]
Its light-absorption process can be simplified as:
AB-E (S₀) + hν → AB-E* (S₁)
where:
• AB-E represents avobenzone in the enol form;
• S₀ represents the electronic ground state;
• S₁ represents the first excited singlet state;
• hν represents the energy of a UVA photon.
The fundamental basis of UVA absorption by avobenzone is the transfer of energy from the incident photon to the molecular electronic system, promoting an electron from the ground state to an excited state.
2.3 Why Does the Diketo Form Lack UVA1 Absorption of Comparable Intensity?
The central structure of the diketo form is:
Ar¹—CO—CH₂—CO—Ar²
The two carbonyl groups are separated by an approximately saturated methylene group, making it difficult to form a continuous conjugated system comparable to that of the chelated enol form. The energy required for electronic transitions is therefore higher, and the absorption spectrum shifts toward shorter wavelengths.
The diketo form is therefore not completely incapable of absorbing ultraviolet radiation, but it lacks the strong long-wave UVA absorption characteristic of the chelated enol form. When irradiation reduces the proportion of the chelated enol form or causes the molecule to adopt a non-chelated, nonplanar structure, absorbance in the UVA1 region decreases.
3 Energy Changes After Avobenzone Absorbs Photons
3.1 Ideal Photophysical Deactivation Process
After absorbing UVA, avobenzone enters an excited state. Because the excited state has a relatively high energy, the molecule must release energy to return to the ground state.
For explanatory purposes, an idealized nonradiative deactivation process can be represented in simplified form as:
AB-E (S₀) + hν → AB-E* (S₁)
AB-E* (S₁) → AB-E (S₀) + heat
During this process, the excited molecule transfers energy to the surrounding medium through nonradiative pathways such as vibrational relaxation and internal conversion. After returning to its original ground-state structure, the molecule can continue to absorb subsequent UVA photons.
This cycle of “light absorption–deactivation–recovery” is the basis for the continuous function of organic ultraviolet filters.
3.2 Three Major Fates of the Excited State
Fate of the excited state | Molecular outcome | Effect on UVA absorption |
Nonradiative deactivation | Returns to the original chelated enol ground state | The molecule can continue to absorb UVA |
Structural transformation | Forms a non-chelated enol form, other geometric isomers, or the diketo form | Long-wave UVA absorption decreases; some processes may recover in the dark |
Photochemical reaction | Undergoes oxidation, radical reactions, rearrangement, or chemical-bond cleavage | The parent molecule is consumed, resulting in an irreversible loss of absorption capacity |
These three processes may compete with one another or occur sequentially. The photostability of avobenzone depends on how much of the excitation energy is released through non-destructive deactivation pathways and how much enters structural-transformation and chemical-degradation pathways.
3.3 Intersystem Crossing and the Triplet Excited State
Some excited singlet-state avobenzone molecules can enter a triplet excited state through intersystem crossing (ISC):
AB* (S₁) → AB* (T₁)
The triplet excited state generally has a longer lifetime, giving the molecule more opportunities to collide with oxygen, oils, other UV filters, or impurities.
Possible pathways of the triplet state include:
① Returning to the ground state;
② Transferring energy to other molecules;
③ Undergoing energy transfer or electron transfer with oxygen;
④ Entering molecular-rearrangement or chemical-bond-cleavage pathways.
The triplet state does not itself mean that avobenzone has already degraded, but its lifetime and reactivity affect the probability of subsequent photochemical reactions.[3]
4 Photoinduced Structural Transformation and Irreversible Photodegradation
4.1 Photoinduced Structural Transformation
Photoinduced structural transformation refers to the conversion of a molecule, after light absorption, into different geometric isomers, conformations, or tautomers while the main molecular skeleton may remain intact.
Possible structural changes in avobenzone include:
① Conversion of the chelated enol form into a non-chelated enol form;
② Changes in the geometric configuration of the double bond in the enol structure;
③ Disruption of the intramolecular hydrogen bond;
④ Twisting between the aromatic rings and the central conjugated framework;
⑤ Shifts in the keto–enol equilibrium.
These changes can reduce molecular planarity, shorten the effective conjugation length, or alter the energy difference between electronic orbitals, thereby weakening UVA1 absorption.
Some structures can reconvert into the chelated enol form after irradiation is discontinued, resulting in a certain degree of dark recovery. Dark recovery indicates that the decrease in absorption does not arise entirely from molecular fragmentation; part of it may result from reversible structural transformation.
4.2 Photolytic Cleavage Reactions
Photolytic cleavage refers to the breaking of covalent bonds after avobenzone absorbs light, producing compounds that differ from the original molecule.
The process can be represented in simplified form as:
Avobenzone + hν → excited-state avobenzone → radicals or highly reactive intermediates → aromatic carbonyl compounds and other degradation products
The β-dicarbonyl region of avobenzone is an important site of photochemical reactions. Depending on the conditions, carbon–carbon bond cleavage at the α-position of a carbonyl group, oxidation, rearrangement, and subsequent radical reactions may occur.
The differences between photoinduced structural transformation and photolytic cleavage are shown below:
Item | Photoinduced structural transformation | Photolytic cleavage |
Main molecular skeleton | Usually retained | Undergoes cleavage or irreversible rearrangement |
Molecular formula | Usually unchanged | New molecules are formed |
Dark recovery | Some structures may recover | Usually cannot revert to the parent molecule |
Cause of reduced protection | Decrease in the proportion of effectively absorbing structures | Decrease in the amount of active avobenzone |
Formation of small-molecule products | Not necessarily | May occur |
4.3 Photooxidation and Oil-Phase Radical Chain Reactions
After absorbing UVA, avobenzone enters an excited state. Most excited molecules can return to the ground state through internal conversion and vibrational relaxation, whereas some may undergo structural transformation, intersystem crossing, or photolysis. Under specific solvent, oxygen-concentration, and formulation conditions, excited-state avobenzone and its primary photolytic intermediates may participate in electron-transfer, hydrogen-transfer, or energy-transfer reactions, producing radical intermediates or reactive oxygen species.
AB + hν → AB*
AB* → R· or other photoreactive intermediates
Here, AB represents avobenzone, AB* represents its excited state, and R· represents a primary radical generated through the photochemistry of avobenzone or other photooxidation processes within the system.
When the formulation contains readily oxidizable lipids, primary radicals may abstract hydrogen atoms from lipid molecules and initiate a lipid-peroxidation chain. The following equations represent one possible pathway of secondary lipid oxidation:
LH + R· → L· + RH
L· + O₂ → LOO·
LOO· + LH → LOOH + L·
where:
• LH represents an oxidizable lipid;
• L· represents a lipid radical;
• LOO· represents a lipid peroxyl radical;
• LOOH represents a lipid hydroperoxide.
The degree of unsaturation of the oils, the initial peroxide value of the raw materials, oxygen diffusion, trace metals, antioxidants, and the structure of the sunscreen film can all affect the progression of lipid peroxidation. Packaging oxygen permeability mainly affects oxidative stability during product storage, whereas after application, oxidation is primarily influenced by contact between the sunscreen film and air and by local diffusion conditions.
5 Photodegradation Products and Cutaneous Photoreactions
5.1 Degradation Products Under Different Experimental Conditions
The degradation products of avobenzone are strongly dependent on the experimental conditions. Light-source wavelength, irradiation dose, solvent, oxygen concentration, water content, pH, metal ions, and residual chlorine can all alter the reaction pathway.
Studies conducted in common organic solvents, oxygen-containing systems, or chlorinated water under ultraviolet irradiation have detected the following types of products:
① Substituted aromatic aldehydes;
② Substituted aromatic acids;
③ Phenolic compounds;
④ Acetophenone-type compounds;
⑤ Chlorinated aromatic derivatives.
Chlorinated products are mainly associated with swimming-pool water or chlorinated-water models. Such experiments reflect reactions caused by the combined effects of ultraviolet radiation, residual chlorine, and the aqueous environment and cannot directly represent the product profile generated by sunscreen under normal conditions on the skin surface.[6]
The oil phase, film-forming agents, antioxidants, sebum, water content, and oxygen-diffusion conditions in a sunscreen film differ from those in dilute solutions or chlorinated-water models. The actual degradation behavior must therefore be evaluated through irradiation testing of the complete finished product.
5.2 Are Arylglyoxals Confirmed Major Products?
Arylglyoxal compounds are α-dicarbonyl compounds with a certain degree of electrophilic reactivity and can react with nucleophilic groups in proteins under suitable conditions.
From the perspective of organic reaction mechanisms, certain oxidation or cleavage pathways of avobenzone may potentially generate reactive carbonyl intermediates. However, current studies have not established arylglyoxals as major photodegradation products that are commonly present under routine conditions of use on the skin.
Published studies more commonly report aromatic aldehydes, aromatic acids, phenolic compounds, and acetophenone-type products, and some of these findings were obtained in aqueous-solution or chlorinated-water systems.[6]
5.3 Protein Binding and Photoallergy
Compounds containing aldehyde groups, α-dicarbonyl groups, or other electrophilic groups may form adducts with lysine, arginine, or cysteine residues in proteins under suitable chemical-reaction conditions.
From the perspective of general chemical sensitization mechanisms, if avobenzone or its photoproducts participate in photocontact sensitization, the following process may theoretically occur:
Photoproduct formation → penetration into the stratum corneum or viable epidermis → reaction with skin proteins → formation of complexes recognizable by the immune system → sensitization → immune response after subsequent exposure
Avobenzone itself and other sunscreen agents can cause contact or photocontact allergy in a small number of individuals. The specific sensitizing source may also involve fragrances, preservatives, other UV filters, and photodegradation products.
6 How Formulations Can Improve the Photostability of Avobenzone
Stabilization strategies for avobenzone mainly focus on four objectives:
① Maintaining uniform dissolution or dispersion of avobenzone in the oil phase and sunscreen film to reduce crystallization;
② Shortening the effective lifetime of highly reactive excited states;
③ Reducing the probability of contact between the excited state and oxygen, metal ions, or incompatible ingredients;
④ Terminating radical chain reactions that have already formed.
6.1 Combination with Octocrylene
The International Nomenclature Cosmetic Ingredient name of octocrylene is Octocrylene. It primarily absorbs UVB and also covers part of the short-wave UVA region. When combined with avobenzone, it may improve system performance in three ways.
① Spectral supplementation
Octocrylene contributes to absorption in the UVB and part of the UVA2 region, whereas avobenzone is primarily responsible for UVA1. Their combination helps produce a more continuous ultraviolet absorption profile.
② Improvement of oil-phase solubility
Octocrylene is an oily, lipophilic ingredient that can improve the oil-phase dissolution of some crystalline UV filters and may reduce the risk of avobenzone crystallization during storage or after film formation.
③ Influence on excited-state processes
Some formulation studies have shown that octocrylene can improve the retention of avobenzone absorbance after irradiation. Its effects may be related to spectral sharing, the oil-phase environment, and intermolecular interactions, although the specific mechanism is formulation-dependent.
6.2 Microencapsulation and Inclusion Technologies
Carrier technologies used for avobenzone include polymeric microcapsules, cyclodextrin inclusion complexes, lipid carriers, and porous inorganic carriers.
These technologies may function through the following mechanisms:
① Reducing direct contact between avobenzone and oxygen, metal ions, or incompatible ingredients;
② Restricting molecular migration and collisions;
③ Modifying the local polarity and hydrogen-bonding environment;
④ Reducing the proportion of free avobenzone;
⑤ Improving the uniformity of its dispersion within the sunscreen film.
Cyclodextrins have a hydrophilic exterior and a relatively hydrophobic internal cavity and can form host–guest inclusion complexes with avobenzone. Some studies have shown that hydroxypropyl-β-cyclodextrin can reduce the photoinduced degradation of avobenzone and alter its transdermal migration behavior.[5]
Encapsulation does not completely isolate avobenzone from light. The carrier must still allow UVA to reach avobenzone while enabling the molecule to release energy effectively after light absorption. Encapsulation efficiency, particle size, carrier transparency, release behavior, and distribution within the sunscreen film can all influence the actual outcome.
6.3 Vitamin E and Antioxidant Systems
Tocopherol in vitamin E can donate a hydrogen atom to lipid peroxyl radicals:
LOO· + Toc-OH → LOOH + Toc-O·
where:
• Toc-OH represents tocopherol;
• Toc-O· represents the tocopheroxyl radical.
The tocopheroxyl radical is less reactive than the lipid peroxyl radical, so this process helps slow radical chain reactions in the oil phase. The primary role of vitamin E is to control secondary oxidation that may be initiated after avobenzone is exposed to light.
Antioxidant efficacy is also influenced by the following factors:
① The specific form and concentration of tocopherol;
② The initial peroxide value of the oil-based raw materials;
③ The oxygen content of the formulation;
④ Whether other antioxidants can participate in regeneration;
⑤ The levels of trace metals and photosensitive impurities.
Some antioxidants have been shown in studies to slow the photodegradation of avobenzone, although their effects are formulation-dependent.[4]
6.4 Control of Metal Ions and Inorganic Particles
Under certain conditions, the β-dicarbonyl structure of avobenzone can coordinate with metal ions such as iron, aluminum, magnesium, and zinc, potentially causing color changes, precipitation, or alterations in photochemical properties.
Metal complexation and metal-catalyzed oxidation can be reduced by controlling metal impurities in raw materials, using appropriate chelating agents, and avoiding incompatible metal salts.
When avobenzone is used together with titanium dioxide or zinc oxide, the surface treatment of the inorganic particles must also be considered. Uncoated particles with relatively high photocatalytic activity may promote the formation of reactive oxygen species, whereas suitable surface coatings can help reduce this interaction.
7 Maximum Permitted Concentrations in Major Markets
The following values represent the maximum permitted concentration of avobenzone in the finished product and are not equivalent to recommended use levels.
Market | Maximum permitted concentration |
China | 5% |
European Union | 5% |
Australia | 5% |
United States | 3% |
Canada | 3% |
Regulatory limits represent the maximum concentration permitted in the finished product and do not directly determine the UVA protection factor. The actual use level must also take the following factors into account:
① The solubility of avobenzone in the oil phase;
② Spectral compatibility with other UV filters;
③ Stability after irradiation;
④ Uniformity of film formation;
⑤ The target Sun Protection Factor (SPF) and Ultraviolet A Protection Factor (UVA-PF);
⑥ Current regulations in the target market.
8 Classification Tables of Chemicals Related to Avobenzone UV Absorption, Photochemical Instability, and Formulation Stability
Table 1. UV Filters and Spectral Compatibility Materials
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Dibenzoylmethane long-wave UVA1 filter | 70356-09-1 | 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)-1,3-propanedione | ≥98% | Compound corresponding to avobenzone; used in studies of the chelated enol structure, keto–enol tautomerism, long-wave UVA1 absorption, excited-state processes, and photodegradation kinetics | |
Aminobenzoyl benzoate long-wave UVA1 filter | 302776-68-7 | Hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate (DHHB) | ≥98% | Used as a photostable long-wave UVA1 absorption reference, for long-wave spectral supplementation, and for studying absorbance retention after irradiation when combined with avobenzone | |
Hydroxyphenyl triazine broad-spectrum filter | 187393-00-6 | Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine | ≥98% | Covers UVA and UVB; used in broad-spectrum combinations, absorption-curve balancing, and studies of avobenzone absorbance retention after irradiation | |
Particulate benzotriazole broad-spectrum filter | 103597-45-1 | 2,2′-Methylenebis[6-(benzotriazol-2-yl)-4-tert-octylphenol] | ≥98% | Used for combined UVA and UVB coverage, particle dispersion, sunscreen-film uniformity, and photostability studies of combinations with avobenzone | |
Benzotriazole siloxane broad-spectrum filter | 155633-54-8 | Drometrizole Trisiloxane | ≥98% | Used for combined UVA and UVB absorption, silicone-oil-phase compatibility, distribution within sunscreen films, and irradiation-stability studies | |
Cyanoacrylate UVB/UVA2 filter | 6197-30-4 | 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate | ≥97% | Compound corresponding to octocrylene; used to supplement UVB and short-wave UVA protection, improve avobenzone solubility, and study photostability synergy in selected formulations | |
Triazine UVB filter | 154702-15-5 | Iscotrizinol | ≥98% | Used to strengthen UVB absorption and supplement part of the UVA2 region, and to study spectral continuity in combined systems and post-irradiation retention | |
Triazine UVB filter | 88122-99-0 | Ethylhexyl Triazone | ≥98% | Used to enhance UVB absorption, reduce short-wave spectral gaps, and construct broad-spectrum avobenzone combination systems | |
Cinnamate UVB filter | 5466-77-3 | 2-Ethylhexyl 4-methoxycinnamate (OMC) | Moligand™, ≥96% (GC) | Used in studies of UVB absorption, interactions between filters, photostability, and the combined absorption spectrum with avobenzone | |
Cyclohexyl salicylate UVB filter | 118-56-9 | 3,3,5-Trimethylcyclohexyl salicylate (cis/trans mixture) | ≥98% | Used in studies of UVB absorption, oil-phase compatibility, dissolution, and film formation in avobenzone combination systems | |
Branched-alkyl salicylate UVB filter | 118-60-5 | Isooctyl salicylate | ≥98% | Combines UVB absorption with oil-phase solvent characteristics; used for avobenzone solubilization, spreading, and combined sunscreen studies | |
Benzophenone UVB/UVA2 filter | 131-57-7 | 2-Hydroxy-4-methoxybenzophenone | ≥99% | Used as a UVB and UVA2 absorption reference and in studies of photochemical interactions between filters and stability in combined systems | |
Benzimidazole sulfonic acid water-phase UVB filter | 27503-81-7 | 2-Phenyl-5-benzimidazolesulfonic acid | ≥95% (T) | Used for water-phase UVB absorption and studies of filter partitioning between oil and water phases, reducing the dissolution load of crystalline filters in the oil phase | |
Zinc oxide inorganic broad-spectrum shielding material | 1314-13-2 | Zinc oxide | Reagent grade, high purity, ≥99.9% metals basis, powder, <5 μm | Used for UVA and UVB shielding, particle dispersion, surface-treatment studies, and investigation of photochemical interactions during coexistence with avobenzone | |
Titanium dioxide inorganic UVB/UVA2 shielding material | 13463-67-7 | T431947 | Titanium dioxide (IV) | Guaranteed reagent, ≥99% | Used for UVB and partial UVA shielding, organic–inorganic combinations, particle-surface photoactivity studies, and evaluation of coating effects |
Table 2. Oil-Phase Solvents, Inclusion Carriers, and Particle Surface-Treatment Materials
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Mineral-oil liquid oil-phase medium | 8042-47-5 | Paraffin | JP, BP, European Pharmacopoeia (Ph. Eur.), NF, highly liquid | Used to investigate the effects of a nonpolar oil phase on avobenzone dissolution, keto–enol equilibrium, oxygen diffusion, and photodegradation rate | |
Fatty acid ester emollient and solubilizer | 110-27-0 | Isopropyl myristate | PharmPure™, European Pharmacopoeia (Ph. Eur.), NF | Used in studies of the dissolution, spreading, film-forming uniformity, and crystallization behavior of avobenzone and other oil-soluble filters | |
Adipate oil-phase solvent | 105-99-7 | Dibutyl adipate (DBA) | ≥99% | Used to solubilize crystalline filters, adjust oil-phase viscosity, and study low-temperature crystallization and dissolution states before and after irradiation | |
Sebacate oil-phase solvent | 7491-02-3 | Diisopropyl sebacate (DIPS) | ≥99% | Used in studies of filter dissolution, molecular diffusion, formulation spreading, and sunscreen-film uniformity | |
Salicylate sunscreen solubilizer | 190085-41-7 | Butyloctyl salicylate | ≥95% | Used for solubilizing avobenzone and crystalline filters and in studies of oil-phase spreading, film formation, and combined absorption spectra | |
Natural cyclodextrin inclusion carrier | 7585-39-9 | β-Cyclodextrin | ≥98% | Used in studies of host–guest inclusion with avobenzone, inclusion ratios, dissolution behavior, and photostability | |
Hydroxypropyl cyclodextrin inclusion carrier | 128446-35-5 | Hydroxypropyl-β-cyclodextrin (HP-β-CD) | PharmPure™, USP | Used in studies of avobenzone inclusion, dispersion, photostability, release, and transdermal-migration models | |
Phospholipid lipid-carrier material | 8002-43-5 | Phospholipids from sunflower (non-GMO) | Natural, with ≥60% phosphatidylcholine | Used to prepare liposomes and lipid nanocarriers and to study avobenzone encapsulation, the local microenvironment, and release behavior | |
Chitosan polysaccharide carrier material | 9012-76-4 | Chitosan | Medium viscosity, 200–400 mPa·s | Used to prepare microparticles, nanocarriers, and composite films and to study avobenzone encapsulation, release, and control of interfacial contact | |
Cellulose ether microcapsule wall material | 9004-57-3 | Ethyl cellulose (EC) | 90–110 mPa·s | Used for microcapsule coating and controlled-release particle preparation and to study the isolation of avobenzone from oxygen and incompatible ingredients | |
Acrylic polymer carrier and film-forming material | 9011-14-7 | P742581 | Poly(methyl methacrylate) (PMMA) | MW ~35,000 | Used in polymer carriers, avobenzone immobilization, optical scattering, and dispersion studies in sunscreen films |
Mesoporous silica carrier | 7631-86-9 | Silicon dioxide | Nanoparticles, mesoporous, outer diameter 450–550 nm, pore size 2–4 nm | Used in studies of avobenzone adsorption, loading, spatial confinement, controlled release, and photodegradation behavior | |
Spherical alumina filler material | 1344-28-1 | Spherical alumina | ≥99.7%, for use as a filler, particle size 5 μm | Used in studies of powder filling, optical scattering, rheological adjustment, particle dispersion, and sunscreen-film structure | |
Fatty acid hydrophobic surface-treatment agent | 57-11-4 | Stearic acid | Suitable for synthesis, Moligand™ | Used for hydrophobic treatment of titanium dioxide, zinc oxide, and inorganic carriers to improve oil-phase dispersion and interfacial compatibility | |
Alkylsilane surface-treatment agent | 2943-75-1 | Triethoxy(octyl)silane | ≥97%, ≥99.99% metals basis, deposition grade | Used for hydrophobic modification of titanium dioxide, zinc oxide, and silicon dioxide and in studies of particle dispersion and surface photochemical interactions |
Table 3. Antioxidants, Analytical Reference Materials, and Metal-Ion Control Agents
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Hindered-phenol chain-breaking antioxidant | 128-37-0 | 2,6-Di-tert-butyl-p-cresol (BHT) | Ultrapure grade, ≥99.5% (GC) | Used to inhibit oil-phase radical chain reactions and lipid peroxidation and to evaluate the photooxidative stability of avobenzone systems | |
Tocopherol lipid-phase chain-breaking antioxidant | 59-02-9 | D-α-Tocopherol | Moligand™, ≥97% (GC) | Used to capture lipid peroxyl radicals and to study oil-phase oxidation and absorbance retention in irradiated avobenzone systems | |
Lipid-soluble ascorbic acid derivative | 137-66-6 | L-Ascorbyl palmitate | PharmPure™, USP | Used for lipid-phase oxidation control and studies of synergy with tocopherol in combined antioxidant systems | |
Phenolic-acid antioxidant research compound | 1135-24-6 | Ferulic acid | Moligand™, ≥99% | Used in studies of radical scavenging, combined antioxidant systems, and ultraviolet absorption spectra; not evaluated for use as a sunscreen filter | |
Quinone-type lipid-soluble redox research compound | 303-98-0 | Coenzyme Q10 | ≥98% | Used in studies of lipid-phase redox processes, radical reactions, and photooxidation in avobenzone formulations | |
Tocopherol-ester stability reference compound | 7695-91-2 | DL-α-Tocopherol acetate | PharmPure™, European Pharmacopoeia (Ph. Eur.) | Used to compare the effects of free tocopherol and esterified forms on oil-phase storage stability, irradiation stability, and formulation compatibility | |
Water-soluble vitamin E analogue and antioxidant-capacity reference compound | 53188-07-1 | Trolox [6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] | ≥98%, white | Used for quantitative evaluation of radical-scavenging capacity, comparison of antioxidant systems, and reference assessment in avobenzone photooxidation experiments | |
Stable-radical detection reagent | 1898-66-4 | 2,2-Diphenyl-1-picrylhydrazyl radical (DPPH, containing 10–20% benzene) | ≥97% (HPLC) | Used to determine the radical-scavenging capacity of tocopherol, ferulic acid, and combined antioxidant systems | |
Aminopolycarboxylic acid metal chelator | 139-33-3 | Disodium ethylenediaminetetraacetate | ≥99% | Used to complex trace metal ions and to study metal-catalyzed oxidation, avobenzone coordination, and formulation stability | |
Polyphosphoric acid metal chelator | 83-86-3 | Phytic acid solution | 70% in H₂O | Used to complex iron, copper, and other metal ions and to study the control of metal-catalyzed oxidation and avobenzone coordination reactions | |
Phytate water-phase chelator | 14306-25-3 | Phytic acid sodium salt hydrate | ≥75% | Used for controlling metal impurities in the aqueous phase of emulsions and for studies of oxidative stability and avobenzone formulation compatibility |
Table 4. Compounds for Molecular-Structure, Candidate-Degradation-Product, and Reaction-Mechanism Studies
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
β-Diketone structural model compound | 120-46-7 | Dibenzoylmethane | ≥98% (GC) | Used in studies of keto–enol tautomerism, intramolecular hydrogen bonding, solvent effects, and excited-state photochemistry of dibenzoylmethane compounds | |
Methoxy aromatic aldehyde research compound | 123-11-5 | p-Anisaldehyde | ≥99% | Used for chromatographic retention-time comparison, mass-spectral fragment analysis, and pathway studies of candidate degradation products derived from the methoxy-substituted aromatic-ring side of avobenzone | |
tert-Butyl aromatic aldehyde research compound | 939-97-9 | 4-tert-Butylbenzaldehyde | ≥97% | Used for chromatographic comparison, degradation-kinetics studies, and pathway verification of candidate degradation products derived from the tert-butyl-substituted aromatic-ring side of avobenzone | |
Methoxy aromatic acid research compound | 100-09-4 | 4-Methoxybenzoic acid | ≥98% | Used for chromatographic comparison of downstream oxidation products of methoxy aromatic aldehydes and for studies of avobenzone oxidation pathways | |
tert-Butyl aromatic acid research compound | 98-73-7 | 4-tert-Butylbenzoic acid | ≥99% | Used for chromatographic comparison, product identification, and degradation-pathway studies of candidate oxidation products derived from the tert-butyl-substituted aromatic-ring side | |
Methoxy aromatic ketone research compound | 100-06-1 | 4-Methoxyacetophenone | ≥99% | Used for chromatographic and mass-spectrometric comparison of candidate aromatic ketone products derived from the methoxy-substituted aromatic-ring side of avobenzone | |
tert-Butyl aromatic ketone research compound | 943-27-1 | 4′-tert-Butylacetophenone | ≥96% | Used for chromatographic comparison of candidate aromatic ketone products derived from the tert-butyl-substituted aromatic-ring side of avobenzone and for photolysis-mechanism studies | |
α-Dicarbonyl reaction model compound | 1074-12-0 | Phenylglyoxal monohydrate | ≥97% (GC) | Used in studies of the electrophilic reactions of reactive dicarbonyl compounds, protein-adduct formation, and the biological reaction mechanisms of potential photodegradation products |
Note: The products listed above are representative Aladdin products related to scientific research and formulation studies. Additional product specifications, grades, and certificate of analysis information can be searched on the Aladdin website using the product name, CAS number, or catalog number.
References
[1] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION. PubChem Compound Summary for CID 51040, Avobenzone[DB/OL]. Bethesda (MD): National Library of Medicine (US).
[2] MTURI G J, MARTINCIGH B S. Photostability of the sunscreening agent 4-tert-butyl-4-methoxydibenzoylmethane (avobenzone) in solvents of different polarity and proticity[J]. Journal of Photochemistry and Photobiology A: Chemistry, 2008, 200(2–3): 410–420. DOI: 10.1016/j.jphotochem.2008.09.007.
[3] PARIS C, LHIAUBET-VALLET V, JIMÉNEZ O, TRULLAS C, MIRANDA M A. A blocked diketo form of avobenzone: photostability, photosensitizing properties and triplet quenching by a triazine-derived UVB filter[J]. Photochemistry and Photobiology, 2009, 85(1): 178–184. DOI: 10.1111/j.1751-1097.2008.00414.x.
[4] AFONSO S, HORITA K, SOUSA E SILVA J P, ALMEIDA I F, AMARAL M H, LOBÃO P A, COSTA P C, MIRANDA M S, ESTEVES DA SILVA J C G, SOUSA LOBO J M. Photodegradation of avobenzone: stabilization effect of antioxidants[J]. Journal of Photochemistry and Photobiology B: Biology, 2014, 140: 36–40. DOI: 10.1016/j.jphotobiol.2014.07.004.
[5] YANG J, WILEY C J, GODWIN D A, FELTON L A. Influence of hydroxypropyl-β-cyclodextrin on transdermal penetration and photostability of avobenzone[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2008, 69(2): 605–612. DOI: 10.1016/j.ejpb.2007.12.015.
[6] TREBŠE P, POLYAKOVA O V, BARANOVA M, BAVCON KRALJ M, DOLENC D, SARAKHA M, KUTIN A, LEBEDEV A T. Transformation of avobenzone in conditions of aquatic chlorination and UV-irradiation[J]. Water Research, 2016, 101: 95–102. DOI: 10.1016/j.watres.2016.05.067.
[7] COMMISSION OF THE EUROPEAN COMMUNITIES. Commission Recommendation of 22 September 2006 on the efficacy of sunscreen products and the claims made relating thereto (2006/647/EC)[Z]. Official Journal of the European Union, 2006, L 265: 39–43.
[8] U.S. FOOD AND DRUG ADMINISTRATION. Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the-Counter Human Use: Final Rule[Z]. Federal Register, 2011, 76(117): 35620–35665.
[9] EUROPEAN PARLIAMENT AND COUNCIL OF THE EUROPEAN UNION. Regulation (EC) No 1223/2009 of 30 November 2009 on cosmetic products (recast)[Z/OL]. Official Journal of the European Union, 2009, L 342: 59–209. Current consolidated version of 1 May 2026, Annex VI, entry 8.
[10] U.S. FOOD AND DRUG ADMINISTRATION. Final Administrative Order (OTC000039): Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information[Z/OL]. Issued June 10, 2026. OTC Monograph M020, § M020.10(b).
[11] HEALTH CANADA, HEALTH PRODUCTS AND FOOD BRANCH. Primary Sunscreen Monograph[EB/OL]. Ottawa: Health Canada, 2026-02-27. Table 2: NPD Medicinal Ingredients.
[12] AUSTRALIAN GOVERNMENT, THERAPEUTIC GOODS ADMINISTRATION. Understanding the Regulation of Therapeutic Sunscreens[EB/OL]. Version 4.0. Canberra: Therapeutic Goods Administration, August 2025. Appendix 3, Table 9: Active Ingredients Restricted for Use in Therapeutic Sunscreens, p. 43.
[13] CHINA FOOD AND DRUG ADMINISTRATION. Announcement on the Issuance of the Safety and Technical Standards for Cosmetics (2015 Edition) (Announcement No. 268 of 2015)[EB/OL]. 2015-12-23. Attachment: Safety and Technical Standards for Cosmetics (2015 Edition), Chapter 2, Table 5, “Permitted Sunscreen Agents.”
For more related articles, see below:
Sources, Biological Functions, Isolation/Characterization, and Emerging Applications of Exosomes
Applicability Comparison of Vitronectin, Laminin and Fibronectin in Cell Culture Coating Systems
Ferulic Acid: Structural Features, Preparation Routes, and Key Points for Research Applications
Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling
How to decipher the whitening code?
Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape
The "Six Key Checkpoints" of Skin Lightening
Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance
Enzymatic Hydroxylation Mechanism of Salicylate Conversion to Catechol
危险品化学品经营许可证(带存储)